RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression
Yohei Abe,Eric R Kofman,Maria Almeida,Zhengyu Ouyang,Filipa Ponte,Jasmine R Mueller,Grisel Cruz-Becerra,Mashito Sakai,Thomas A Prohaska,Nathanael J Spann,Ana Resende-Coelho,Jason S Seidman,Joshua D Stender,Havilah Taylor,Weiwei Fan,Verena M Link,Isidoro Cobo,Johannes C M Schlachetzki,Takao Hamakubo,Kristen Jepsen,Juro Sakai,Michael Downes,Ronald M Evans,Gene W Yeo,James T Kadonaga,Stavros C Manolagas,Michael G Rosenfeld,Christopher K Glass
DOI: https://doi.org/10.1016/j.molcel.2023.08.029
2023-10-05
Abstract:The nuclear receptor co-repressor (NCoR) complex mediates transcriptional repression dependent on histone deacetylation by histone deacetylase 3 (HDAC3) as a component of the complex. Unexpectedly, we found that signaling by the receptor activator of nuclear factor κB (RANK) converts the NCoR/HDAC3 co-repressor complex to a co-activator of AP-1 and NF-κB target genes that are required for mouse osteoclast differentiation. Accordingly, the dominant function of NCoR/HDAC3 complexes in response to RANK signaling is to activate, rather than repress, gene expression. Mechanistically, RANK signaling promotes RNA-dependent interaction of the transcriptional co-activator PGC1β with the NCoR/HDAC3 complex, resulting in the activation of PGC1β and inhibition of HDAC3 activity for acetylated histone H3. Non-coding RNAs Dancr and Rnu12, which are associated with altered human bone homeostasis, promote NCoR/HDAC3 complex assembly and are necessary for RANKL-induced osteoclast differentiation in vitro. These findings may be prototypic for signal-dependent functions of NCoR in other biological contexts.